3-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF METABOLIC DISORDERS

The picsenl invention provides novel compounds represented by the general formula (I): wherein Ar is a quinoline or isoquinoline moiety which is subs tituted or unsubstituted; B is -O. -S-. or -NH-: R1 is hydrogen or S(O)2R4: R2 is S(O)2R4. C(O)OR5. or C(O)(CH2)n-C(O)OR6: R3 is halogen, cyano, C(O)O...

Full description

Saved in:
Bibliographic Details
Main Authors KULKARNI, RHUSHIKESH ARUN, PADIYA, KAMLESH JYOTINDRA, MARITA, ROSALIND ADAIKALASAMY, BAJARE, SWAPNIL RAMESH, HARIHARAN, SIVARAMAKRISHNAN, DEKA, NABAJYOTI, KHAN, TAJ USMAN
Format Patent
LanguageEnglish
French
Published 27.03.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The picsenl invention provides novel compounds represented by the general formula (I): wherein Ar is a quinoline or isoquinoline moiety which is subs tituted or unsubstituted; B is -O. -S-. or -NH-: R1 is hydrogen or S(O)2R4: R2 is S(O)2R4. C(O)OR5. or C(O)(CH2)n-C(O)OR6: R3 is halogen, cyano, C(O)OR7 . or C(O)NR8R9: R4 is aryl: R5 is (C1-C6)alkyl or aryl: R6 is hydrogen. (C1- C4)alkyl. or aryl: R7 is hydrogen or (C1-C4)alkyl: R8 and R9 are independent ly hydrogen or (C1-C6)alkyl; n is an integer from 1-3: and a pharmaceuticall y acceptable salt or solvate thereof. their pharmaceutically acceptable salt s and their pharmaceutically acceptable solvates thereof, which are useful i n treating metabolic disorders related to insulin resistance or hyperglycemi a. The invention also relates to a process for the manufacture of compounds of formula (I) and pharmaceutical compositions containing them.
Bibliography:Application Number: CA20072663943